Forbes October 8, 2021
A debate is raging over the cost of drugs in the United States and around the world.
For at least three billion people in India and China, drug costs are determined by the manufacturing price, plus a modest market profit for suppliers and pharmaceutical wholesalers and retailers. Not so in the more “regulated markets” of North America and Europe.
One example I have described in detail is the cost of a two-drug, three-month curative therapy for hepatitis C, which is about $80,000 in the United States and $45 (no zeros missing) in Egypt and India. At that cost, the government of Egypt, until recently the country with the highest per capita burden of chronic hepatitis C, eliminated the disease from...
Today's Sponsors
Today's Sponsor